NEW YORK, Sept. 10, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Intravenous Solutions Market 2011-2015
http://www.reportlinker.com/p0962698/Global-Intravenous-Solutions-Market...
TechNavio's analysts forecast the Global Intravenous Solutions market to grow at a CAGR of 12.08 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing cases of out-patient intravenous therapies. The Global Intravenous Solutions market has also been witnessing an increasing focus on product launches. However, the adverse effects of ketorolac trometamol could pose a challenge to the growth of this market.
TechNavio's report, the Global Intravenous Solutions Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intravenous Solutions market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include B. Braun Melsungen AG, Baxter International Inc., Hospira Inc., and Pfizer Inc.
Other vendors mentioned in the report: Fresenius Kabi AG, Liqvor Pharmaceuticals CJSC, Watson Pharmaceuticals Inc., Claris Lifesciences Ltd., Galenica Ltd., Grifols S.A., Sichuan Kelun Pharmaceutical Co. Ltd., Marck Biosciences Ltd., Otsuka Pharmaceutical Co. Ltd., Sino-Swed Pharmaceutical Corp. Ltd., and Terumo Medical Corp.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Offerings
04. Market Landscape
04.1 Market Size and Forecast
04.2 Key Market Segmentation
04.3 Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
USA
Germany
Japan
07. Rate of Incidence and Prevalence
Diabetes
Cancer
AIDS
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Baxter International Inc.
Business Overview
SWOT Analysis
15.2 B. Braun Melsungen AG
Business Overview
SWOT Analysis
15.3 Hospira Inc.
Business Overview
SWOT Analysis
15.4 Pfizer Inc.
Business Overview
SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Intravenous Solutions Market 2011-2015 (US$ billion)
Exhibit 2: Global Intravenous Solutions Market by Application Segmentation 2011
Exhibit 3: Global Intravenous Solutions Market by Geographical Segmentation 2011
Exhibit 4: Global Intravenous Solutions Market by Vendor Segmentation 2011
Exhibit 5: Adverse Effects of Ketorolac Trometamol
Exhibit 6: Business Segmentation of Baxter International Inc.
Exhibit 7: Business Segmentation of Hospira Inc.
To order this report:
Pathology Industry: Global Intravenous Solutions Market 2011-2015
Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
